In this powerful episode of “Let’s Be Blunt with Montel,” Montel Williams speaks with Alison Myrden, a retired corrections officer, drug
law reform activist, and MS warrior. Diagnosed with chronic progressive Multiple Sclerosis and severe Trigeminal Neuralgia in 1992, Alison’s life took an unexpected turn that led her to become one of the world’s first medical cannabis patients.
Alison shares her unique perspective on the war on drugs, shaped by her years working in the Youth Court Justice system, where she witnessed
firsthand the criminalization of young offenders for experimenting with drugs, especially cannabis. She recounts her personal journey of managing excruciating pain through medical cannabis and other alternative therapies, long before they were widely accepted
in Canada.
In this episode, you’ll learn:
The challenges Alison faced as a corrections officer and how it influenced her views on drug reform.
How she became a passionate advocate for medical cannabis, securing federal exemptions and fighting for patient rights.
The current landscape for medical cannabis and psilocybin patients in Canada.
Misconceptions about medical cannabis and its role in chronic pain management.
The importance of education in changing public perceptions and impacting policy reforms.
Alison’s advocacy work has made significant strides towards the full legalization and responsible regulation of all drugs, emphasizing
that the war on drugs is, in fact, a war on people. Her story is a testament to resilience, compassion, and the relentless pursuit of justice.
Tune in to hear Alison Myrden’s inspiring story and gain insights into the future of drug policy reform. Don’t miss this compelling conversation
on “Let’s Be Blunt with Montel.”
Listen now and join us in pushing for a fairer, more compassionate approach to drug laws and medical access.
This is the A block of this week’s Weed Talk News with Alaina Pinto. The full show is available now on demand at procannabismedia.com.
History was made in Washington DC when the DEA accepted the HHS recommendation to move cannabis to schedule 3 of the Controlled Substances Act. For the first time, a federal agency has enough evidence of the medicinal capabilities of the cannabis plant to get it away from Heroin and put it in the same schedule as anabolic steroids & Codeine Tylenol. Its not official until the White House Budget review and a public comment period. Industry reaction is mixed, consumer reaction is what took so long?
Success Center is a community-based organization that was founded 35 years ago by Superior Court Judges in San Francisco to provide education and employment opportunities to youth in juvenile detention facilities. The program has recently expanded to include Equity for Industry training and workshops for those interested in the cannabis industry. Liz Jackson-Simpson, CEO of Success Centers, and Angela White, Program Manager for Equity for Industry, talk with Montel about the program and the challenges minorities face when looking to enter the cannabis industry, and how their programs address those challenges.
#successcentersikar #cannabis #equity #420 #weed #thc #cannabiseducation #cannabiscommunity #cannabisculture
Reaction from NECANN Baltimore to the suggested move to schedule 3 by the DEA on the classification of cannabis. Virginia’s Joe Parsons has that story. Amie Carter from Michigan with a story about a Detroit School Boss trying to change the edible packaging regulations. Doug Miller is High on Wall Street with a look at Canopy Growth and the impact of the DEA decision on the stock market. Tina Tasaka from Las Vegas Nevada where Planet 13 is expanding. All that and more state reports on Weed Talk News with Alaina Pinto.